Fact.MR notes that demand for closed IV spikes is increasing as healthcare providers strengthen safe infusion practices. Hospitals and pharmacies are adopting closed fluid transfer products to reduce contamination risk and improve medication handling.
USD 335 million in 2026 to USD 760 million by 2036 at 8.5% CAGR.
USD 425 million absolute opportunity by 2036 led by the United States and Germany.
Closed IV spikes are sterile transfer devices used to access IV bags or bottles while minimizing leakage, contamination risk, and exposure during medication preparation or infusion. They support safer medication preparation and infusion across hospitals and pharmacies.
The United States is projected to record 8.9% CAGR through 2036 because hospitals continue strengthening infusion safety programs. Germany is expected to grow at 8.6% CAGR due to wider adoption of closed fluid transfer products. Japan is forecast to expand at 8.4% CAGR as healthcare providers improve medication safety practices. China is projected to register 8.2% CAGR through 2036 because hospital infrastructure continues expanding. South Korea is expected to grow at 8.0% CAGR due to increasing investment in oncology and infusion services.
Closed Spikes lead at 35.0%. Hospitals lead at 58.0%.
Closed Spikes hold 35.0% share in 2026.
Closed spikes lead because they reduce fluid exposure during medication preparation. They help maintain a sterile transfer path while lowering contamination risk. Healthcare providers prefer these products because they support safer infusion practices. They also improve handling of high value medications. Demand remains strong across hospital pharmacies and infusion units. Epic Medical Pte. Ltd. received FDA 510(k) clearance for the ZeroClear™ Bag Access, a component of the ProSeal™ Closed System Drug Transfer Device (CSTD) system. The device features an ISO 8536-4:2019 compliant IV bag spike and a bi-directional Luer lock connector for injecting and infusing IV fluids and drug solutions.
Needle-Free systems account for 33.0% share in 2026.
Needle-free designs remain the leading safety feature because they reduce accidental needlestick injuries. They also simplify fluid transfer during routine clinical practice. Healthcare facilities continue adopting these systems to improve staff safety. Compatibility with existing infusion equipment further supports demand. The Centers for Disease Control and Prevention continues to recommend the use of needleless intravascular catheter systems as part of evidence-based strategies to prevent occupational needlestick injuries and improve injection safety.
IV Fluids hold 39.0% share in 2026.
IV fluids generate the highest demand because they are administered across almost every healthcare setting. Large procedure volumes continue supporting regular product use. Closed IV spikes help maintain sterile fluid transfer throughout preparation. They also reduce leakage during administration. Demand remains steady across acute and long-term care. B. Braun highlighted continued investments to increase the production of IV fluids and infusion therapy devices, including tubing, valves, connectors, and related products, to help meet sustained healthcare demand during the 2024 IV fluid shortage.
Hospitals lead with 58.0% share in 2026.
Hospitals remain the largest end users because they perform the highest number of infusion procedures. They also follow strict medication handling and infection prevention protocols. Many healthcare facilities continue replacing conventional transfer devices with closed systems. This improves workflow while supporting patient safety. Demand remains highest across large medical centers. In 2024, the Infusion Nurses Society updated its Infusion Therapy Standards of Practice, reinforcing the use of aseptic technique, needleless connectors, and closed infusion systems to reduce contamination and catheter-related infections in healthcare settings.
Safe medication handling supports growth, while product cost remains a challenge.
Healthcare providers continue strengthening infusion safety practices to reduce contamination risk. Wider use of hazardous drugs is also increasing demand for closed transfer products. Growth in oncology treatment and sterile compounding continues supporting product adoption.
Updated healthcare guidelines further encourage safer medication preparation. Higher product cost remains a challenge for smaller healthcare facilities. Budget limitations may slow adoption in price-sensitive markets.
United States 8.9%, Germany 8.6%, Japan 8.4%, China 8.2%, South Korea 8.0%.
Regional demand continues rising as healthcare providers strengthen infusion safety practices and improve sterile medication preparation. North America leads regional demand, while Asia Pacific continues creating opportunities through healthcare infrastructure expansion.
.webp "Top Country Growth Comparison Closed Iv Spikes Market Cagr (2026 2036)")
| Country | CAGR (2026-2036) |
|---|---|
| United States | 8.9% |
| Germany | 8.6% |
| Japan | 8.4% |
| China | 8.2% |
| South Korea | 8.0% |
8.9% CAGR, supported by advanced infusion safety practices
The United States is projected to expand at an 8.9% CAGR through 2036 because hospitals perform a large number of intravenous therapy procedures. Healthcare providers are expanding the use of closed transfer devices to improve medication safety. Oncology treatment volumes also continue increasing. Strong infection prevention programs further support product adoption. The country leads market revenue contribution.
8.6% CAGR, driven by safe medication handling
Germany is expected to grow at an 8.6% CAGR by 2036 because hospitals and compounding pharmacies continue expanding the use of closed IV spikes. Healthcare providers place strong emphasis on sterile preparation of injectable medicines. Growing adoption of closed transfer systems supports safer clinical practice. Hospital quality initiatives also contribute to steady market growth. Germany remains a key market across Western Europe.
8.4% CAGR, backed by healthcare quality improvements
Japan is forecast to register an 8.4% CAGR because hospitals and specialty care facilities continue increasing the use of closed IV spikes. Demand is supported by greater focus on medication safety and infection prevention. Healthcare providers continue modernizing infusion practices. This supports stable demand throughout the forecast period.
8.2% CAGR, supported by expanding hospital capacity
China is projected to expand at an 8.2% CAGR because investment in modern hospitals and advanced pharmacy services continues increasing. Demand for closed transfer products is rising as healthcare providers strengthen contamination control practices. Higher treatment volumes and growing oncology services continue supporting market expansion. China remains one of Asia’s higher-growth markets.
8.0% CAGR, supported by oncology care expansion
South Korea is expected to record an 8.0% CAGR by 2036 because hospitals continue improving infusion safety through greater use of sterile transfer products. Adoption of closed IV spikes is increasing to improve medication handling. Demand is also supported by expanding oncology services and critical care capacity. Continued healthcare investment supports long-term growth.
B. Braun, ICU Medical, JMS maintain strong positions
Manufacturers are focusing on safer fluid transfer technologies that reduce contamination during medication preparation. Product development also emphasizes leak prevention and compatibility with different IV containers and infusion systems.
Hospitals remain the largest customer group because they perform the highest volume of infusion procedures. Oncology centers continue increasing purchases as hazardous drug handling requirements become stricter. Compounding pharmacies are also expanding the use of closed IV spikes to improve sterile preparation practices.
IV fluids account for the largest application because they are administered across nearly every healthcare setting. Oncology drugs and biologics also generate consistent demand as sterile handling requirements continue increasing.
B. Braun maintain strong positions through broad infusion therapy portfolios. ICU Medical and Fresenius Kabi continue expanding closed transfer technologies for safer medication delivery. CODAN continue strengthening their presence through product innovation, broader distribution and clinical support. Companies that deliver dependable product quality, strong compatibility and reliable clinical performance are expected to strengthen their market position through 2036.
B. Braun, ICU Medical, Fresenius Kabi, CODAN, Vygon, JMS
Closed transfer spikes designed for sterile IV fluid access.
The market covers disposable IV spikes used to transfer fluids from bottles and bags while reducing contamination and leakage during infusion preparation.
Closed IV transfer products.
The scope includes vented spikes, non-vented spikes, closed spikes, bag spikes and bottle spikes.
Conventional IV spikes without closed transfer features.
The scope excludes infusion pumps, IV sets, and standard administration tubing.
100+ sources, 30+ company assessments, 25+ countries, and industry interviews.
| Attribute | Details |
|---|---|
| Quantitative Units | USD Million in 2026 to USD Million by 2036 at CAGR |
| Market Definition | Closed IV spikes designed for sterile fluid transfer during medication preparation and infusion |
| Spike Types Covered | Vented Spikes, Non-Vented Spikes, Closed Spikes, Bag Spikes, Bottle Spikes |
| Safety Features Covered | Drip-Free, Needle-Free, Air-Filtered, Antimicrobial, Closed-System Compatible |
| Fluid Types Covered | IV Fluids, Oncology Drugs, Parenteral Nutrition, Antibiotics, Biologics |
| End Users Covered | Hospitals, Oncology Centers, Home Infusion, Compounding Pharmacies, ASCs |
| Regions Covered | North America, Western Europe, Asia Pacific, Latin America, Middle East & Africa |
| Key Countries Covered | United States, Germany, Japan, China, South Korea |
| Companies Covered | B. Braun, ICU Medical, Fresenius Kabi, CODAN, Vygon, JMS |
| Forecast Period | 2026 to 2036 |
| Research Approach | Hybrid top-down and bottom-up methodology using infusion procedure volumes, medication preparation practices and hospital purchasing analysis. |
Which spike type accounts for the largest market share?
Closed spikes lead because they reduce contamination risk and support sterile medication transfer during infusion preparation.
Why do IV fluids generate the highest demand?
IV fluids are administered across most healthcare settings, creating consistent demand for closed transfer products.
What is driving market growth?
Growing emphasis on infusion safety and wider adoption of closed transfer systems continue supporting market expansion.
Which country expands fastest in the Closed IV Spikes Market?
The United States is expected to record the highest CAGR because healthcare providers continue strengthening safe infusion practices.
What is the biggest challenge for manufacturers?
Higher product costs and compliance with evolving safety requirements remain key challenges across healthcare markets.
Which end-user segment generates the highest demand?
Hospitals account for the largest share because they perform the highest number of intravenous therapy procedures.
Why are needle-free safety features widely adopted?
They reduce needlestick injuries while improving safety during medication preparation and administration.
How are compounding pharmacies influencing demand?
Growing sterile compounding activity continues increasing the use of closed IV spikes for safe fluid transfer.
What opportunities are emerging for manufacturers?
Expansion of oncology services and home infusion therapy continues creating new opportunities for closed transfer products.
Closed IV Spikes Market